Future studies will be needed to more fully determine the feasibility of using CXCL13 as a biomarker for AIDS-NHL, as well as to define the function of CXCL13 and CXCR5 in the pathogenesis of AIDS-NHL. This evidence concerns the gene CXCR5 and non-Hodgkin lymphoma.